Poor prognostic factors in human papillomavirus- positive head and neck cancer: who might not be candidates for de-escalation treatment?
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Since patients with human papillomavirus (HPV)-associated head and neck squamous cell carcinoma (HNSCC) have favorable outcomes after treatment, treatment de-escalation for these patients is being actively investigated. However, not all HPV-positive HNSCCs are curable, and some patients have a poor prognosis. The purpose of this study was to identify poor prognostic factors in patients with HPV-positive HNSCC. Methods: Patients who received a diagnosis of HNSCC and tested positive for HPV from 2000 to 2015 at a single hospital site (n = 152) were included in this retrospective analysis. HPV typing was conducted using the HPV DNA chip assay or liquid bead microarray system. Expression of p16 in the tumors was assessed by immunohistochemistry. To determine candidate factors associated with overall survival (OS), univariate and multivariable Cox regression analyses were performed. Results: A total of 152 patients with HPV-positive HNSCC were included in this study; 82.2% were male, 43.4% were current or former smokers, and 84.2% had oropharyngeal cancer. By univariate analysis, old age, performance status ≥ 1, non-oropharyngeal location, advanced T classification (T3–4), and HPV genotype 18 were significantly associated with poor OS. By multivariable analysis, performance status ≥ 1 and non-oropharyngeal location were independently associated with shorter OS (hazard ratio [HR], 4.36, p = 0.015; HR, 11.83, p = 0.002, respectively). Furthermore, HPV genotype 18 positivity was also an independent poor prognostic factor of OS (HR, 10.87, p < 0.001). Conclusions: Non-oropharyngeal cancer, poor performance status, and HPV genotype 18 were independent poor prognostic factors in patients with HPV-positive HNSCC. Patients with these risk factors might not be candidates for de-escalation treatment.
Abstract
Background/Aims: Since patients with human papillomavirus (HPV)-associated head and neck squamous cell carcinoma (HNSCC) have favorable outcomes after treatment, treatment de-escalation for these patients is being actively investigated. However, not all HPV-positive HNSCCs are curable, and some patients have a poor prognosis. The purpose of this study was to identify poor prognostic factors in patients with HPV-positive HNSCC. Methods: Patients who received a diagnosis of HNSCC and tested positive for HPV from 2000 to 2015 at a single hospital site (n = 152) were included in this retrospective analysis. HPV typing was conducted using the HPV DNA chip assay or liquid bead microarray system. Expression of p16 in the tumors was assessed by immunohistochemistry. To determine candidate factors associated with overall survival (OS), univariate and multivariable Cox regression analyses were performed. Results: A total of 152 patients with HPV-positive HNSCC were included in this study; 82.2% were male, 43.4% were current or former smokers, and 84.2% had oropharyngeal cancer. By univariate analysis, old age, performance status ≥ 1, non-oropharyngeal location, advanced T classification (T3–4), and HPV genotype 18 were significantly associated with poor OS. By multivariable analysis, performance status ≥ 1 and non-oropharyngeal location were independently associated with shorter OS (hazard ratio [HR], 4.36, p = 0.015; HR, 11.83, p = 0.002, respectively). Furthermore, HPV genotype 18 positivity was also an independent poor prognostic factor of OS (HR, 10.87, p < 0.001). Conclusions: Non-oropharyngeal cancer, poor performance status, and HPV genotype 18 were independent poor prognostic factors in patients with HPV-positive HNSCC. Patients with these risk factors might not be candidates for de-escalation treatment.
참고문헌 (22)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012", Cancer Research and Treatment, 47(2), pp.127~141 (2015), 대한암학회[DOI]
- Ragin CC, "Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection : review and meta-analysis", Int J Cancer, 121, pp.1813~1820 (2007)
- Ang KK, "Human papillomavirus and survival of patients with oropharyngeal cancer", N Engl J Med, 363, pp.24~35 (2010)
- Mirghani H, "Treatment de-escalation in HPV-positive oropharyngeal carcinoma : ongoing trials, critical issues and perspectives", Int J Cancer, 136, pp.1494~1503 (2015)
- "NCCN Guidelines for Head and Neck Cancers Version 2.2016" (2016)[URL]
- Edge SB, "AJCC Cancer Staging Manual" (2010), Springer
- Ock CY, "Effect of induction chemotherapy on survival in locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy : single center experience", Head Neck, 38, pp.277~284 (2016)
- Lim Y, "Clinical outcomes of radiation-based locoregional therapy in locally advanced head and neck squamous cell carcinoma patients not respond-ing to induction chemotherapy", Oral Surg Oral Med Oral Pathol Oral Radiol, 116, pp.55~60 (2013)
- Eisenhauer EA, "New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)", Eur J Cancer, 45, pp.228~247 (2009)
- Lee HS, "Human papillomavirus genotyping using HPV DNA chip analysis in Korean women", Int J Gynecol Cancer, 17, pp.497~501 (2007)
- Choi YD, "Detection of HPV genotypes in cervical lesions by the HPV DNA Chip and sequencing", Gynecol Oncol, 98, pp.369~375 (2005)
- Oh Y, "Polymerase chain reaction-based fluorescent Luminex assay to detect the presence of human papillomavirus types", Cancer Sci, 98, pp.549~554 (2007)
- Kreimer AR, "Human papillomavirus types in head and neck squamous cell carcinomas worldwide : a systematic review", Cancer Epidemiol Biomarkers Prev, 14, pp.467~475 (2005)
- No JH, "Prevalence and prognostic value of human papillomavirus genotypes in tonsillar squamous cell carcinoma : a Korean multicenter study", Cancer, 121, pp.535~544 (2015)
- Kim HR, "PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients", Sci Rep, 6, pp.36956~ (2016)
- Bratman SV, "Human papillomavirus genotype association with survival in head and neck squamous cell carcinoma", JAMA Oncol, 2, pp.823~826 (2016)
- Isayeva T, "Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review", Head Neck Pathol, (6 Suppl 1), pp.S104~S120 (2012)
- Rodriguez T, "Risk factors for oral and pharyngeal cancer in young adults", Oral Oncol, 40, pp.207~213 (2004)
- Fouret P, "Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers", Arch Otolaryngol Head Neck Surg, 123, pp.513~516 (1997)
- Gillison ML, "Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers", J Natl Cancer Inst, 100, pp.407~420 (2008)
- Applebaum KM, "Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer", J Natl Cancer Inst, 99, pp.1801~1810 (2007)
- Schache AG, "Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma : sensitivity, specificity, and prognostic discrimination", Clin Cancer Res, 17, pp.6262~6271 (2011)